Stay updated on Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial
Sign up to get notified when there's something new on the Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial page.

Latest updates to the Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new Revision: v3.6.5 is added, signaling an updated version of the record history. The update appears to adjust the presentation of the history rather than changing the study data.SummaryDifference19%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision v3.6.4 was added to the history, replacing v3.6.3. This indicates an administrative update to the page's revision metadata rather than substantive content changes.SummaryDifference0.0%

- Check51 days agoChange DetectedA new version entry (v3.6.3) was added on 2026-07-02, updating the Study Status and Contacts/Locations sections. This reflects the current trial state and the sites and contact details associated with the study.SummaryDifference0.1%

- Check58 days agoChange DetectedThe revision label on the Record History page was updated from v3.6.0 to v3.6.2, signaling a new site release. This appears to be a background update rather than substantive changes to the study history content.SummaryDifference0.0%

- Check65 days agoChange DetectedNew history entries show updated Study Status and added Contacts/Locations for the trial, reflecting changes in its current operational status and contact points; an earlier version entry dated 2026-06-02 was removed.SummaryDifference0.1%

- Check72 days agoChange DetectedThe history now includes a note that recruitment is no longer looking for participants. It also records a new revision tag v3.6.0 and removes the preceding v3.5.5 revision.SummaryDifference0.0%

Stay in the know with updates to Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial page.